Home LiteratureArticle Details
PMID: 2955070 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.

The Journal of experimental medicine ·Vol. 166 ·No. 2 ·1987-08-01 ·Pages 303-18

Cozzolino F, Torcia M, Carossino AM, Giordani R, Selli C, Talini G, Reali E, Novelli A, Pistoia V, Ferrarini M

Abstract

The specific immune response against the malignant cells was investigated in patients with urinary bladder or larynx cancer. Lymphocytes from lymph nodes that drain the tumor site were tested for their proliferative and cytotoxic capacities against autologous malignant cells isolated from the primary tumor. In no occasion was a proliferative or a cytotoxic response observed. However, when the lymph node cell suspensions were depleted of cells expressing both OKM1 and Leu-7 markers by rosetting with the appropriate mAbs, a proliferative response could be observed. The lymphocytes responded to autologous tumor cells only if IL-2 was added to the cultures. IL-2 alone induced some cell proliferation, which was not, however, comparable to that observed in response to both IL-2 and tumor cells. A panel of allogeneic tumor cells consistently failed to stimulate OKM1-, Leu-7- cells in vitro. Response to autologous tumor cells was not caused by HLA-encoded molecules, as occurs in the autologous mixed lymphocyte reaction, since OKM1-, Leu-7- cells failed to be stimulated by autologous non-T cells. A proliferative response was observed only with cells from lymph nodes that had been classified as invaded by malignant cells according to histopathologic criteria. Cells from noninvaded lymph nodes consistently failed to respond. Cells stimulated with autologous tumor cells could be expanded in short-term lines by continuous addition of IL-2 and malignant cells. One of these lines, which comprised mainly T8+ cells, was stimulated to proliferate only by autologous tumor cells, and its proliferative response was inhibitable by anti-class I and not by anti-class II mAbs. This line showed lytic capacities against autologous malignant targets, while it was inefficient against all of the other allogeneic cells tested. In another set of experiments, the mechanisms whereby exogenous IL-2 had to be added to the cultures to sustain a proliferative response against neoplastic cells were investigated. When cocultured with autologous malignant cells, OKM1-, Leu-7- lymphocytes expressed IL-2 receptors, as could be assessed by anti-Tac fluorescent staining. Under these culture conditions, these cells did not produce IL-2, and no proliferation was observed. Addition of purified IL-1 to the cultures induced IL-2 production and cell proliferation. It is concluded that metastatic lymph nodes contain a T cell population that can be detected in a proliferative assay when both suppressor cells are removed and the appropriate molecular signals are supplied.

MeSH Terms
Antigens, Surface/analysis Cytotoxicity, Immunologic Humans Interleukin-2/immunology Laryngeal Neoplasms/immunology Lymph Nodes/immunology Lymphatic Metastasis Lymphocyte Activation Lymphocyte Depletion Lymphocytes/immunology T-Lymphocytes/immunology T-Lymphocytes, Regulatory/immunology Urinary Bladder Neoplasms/immunology
Chemicals
Antigens, Surface Interleukin-2
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Cozzolino F
Torcia M
Carossino A M
Giordani R
Selli C
Talini G
Reali E
Novelli A
Pistoia V
Ferrarini M
References (45)
45 references, click to expand
  1. Comparative study of membrane and intracytoplasmic immunoglobulin classes in human lymphoid cells.
    Ann N Y Acad Sci. 1975 Jun 30;254:243-53 PMID: 810057
  2. Ia antigen expression and IL-1 activity in murine tumour-associated macrophages.
    Immunology. 1986 Dec;59(4):527-33 PMID: 3492438
  3. The differentiation and function of human T lymphocytes.
    Cell. 1980 Apr;19(4):821-7 PMID: 6991122
  4. Characterization of a human B lymphocyte-specific antigen.
    J Immunol. 1980 Oct;125(4):1678-85 PMID: 6157744
  5. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
    J Immunol. 1981 Apr;126(4):1393-7 PMID: 6970774
  6. Analysis of HLA-DR polymorphism by two-dimensional peptide mapping.
    Proc Natl Acad Sci U S A. 1981 Jan;78(1):534-8 PMID: 6787592
  7. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).
    J Immunol. 1981 Sep;127(3):1024-9 PMID: 6790607
  8. Antigen-dependent proliferation of cloned continuous lines of H-2-restricted influenza virus-specific cytotoxic T lymphocytes.
    J Immunol. 1981 Sep;127(3):1201-4 PMID: 6167621
  9. Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody.
    J Exp Med. 1982 Jan 1;155(1):321-6 PMID: 7054358
  10. Helper T cells for cytotoxic T lymphocytes need not be I region restricted.
    J Exp Med. 1982 Jun 1;155(6):1766-84 PMID: 6176668
  11. Autologous mixed lymphocyte reaction in the peripheral blood and pleural effusions of cancer patients.
    J Clin Invest. 1982 Jul;70(1):98-104 PMID: 6211464
  12. Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies.
    J Immunol. 1983 Jan;130(1):145-52 PMID: 6183346
  13. Regulation of the immune response to antigens on the malignant cell surface.
    Springer Semin Immunopathol. 1982;5(2):175-92 PMID: 6293112
  14. A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses.
    Eur J Cancer Clin Oncol. 1982 Oct;18(10):991-1000 PMID: 6984388
  15. A rapid rosette technique for quantitation and separation of mononuclear cell subsets using monoclonal antibodies.
    J Immunol Methods. 1982 Dec 17;55(2):213-9 PMID: 6984450
  16. Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation.
    J Exp Med. 1983 Apr 1;157(4):1101-15 PMID: 6300278
  17. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
    J Exp Med. 1983 May 1;157(5):1448-60 PMID: 6189937
  18. NKP-15: a monoclonal antibody reactive against purified human natural killer cells and granulocytes.
    Immunol Lett. 1983 Mar;6(3):143-9 PMID: 6862527
  19. Interactions between MHC-encoded products and cloned T-cells. I. Fine specificity of induction of proliferation and lysis.
    Immunogenetics. 1982;16(6):533-49 PMID: 6190737
  20. Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.
    J Immunol. 1983 Dec;131(6):2757-61 PMID: 6227665
  21. A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule.
    J Exp Med. 1983 Dec 1;158(6):1785-1803 PMID: 6196430
  22. Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway.
    Proc Natl Acad Sci U S A. 1984 Mar;81(5):1509-13 PMID: 6231642
  23. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
    J Exp Med. 1984 May 1;159(5):1295-311 PMID: 6232335
  24. Idiotype network interactions in tumor immunity.
    Adv Cancer Res. 1984;41:291-321 PMID: 6203338
  25. Expression and development of macrophage activation for tumor cytotoxicity.
    Contemp Top Immunobiol. 1984;13:127-46 PMID: 6375953
  26. Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.
    J Immunol. 1984 Aug;133(2):764-8 PMID: 6330202
  27. The murine antitumor immune response and its therapeutic manipulation.
    Adv Immunol. 1984;35:89-155 PMID: 6235727
  28. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.
    J Immunol. 1984 Dec;133(6):3054-61 PMID: 6092466
  29. Antigenic stimulation regulates the expression of IL 2 receptors in a cytolytic T lymphocyte clone.
    J Immunol. 1985 Feb;134(2):931-9 PMID: 2578166
  30. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release.
    J Exp Med. 1984 Dec 1;160(6):1717-35 PMID: 6239901
  31. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.
    J Immunol. 1985 Apr;134(4):2444-8 PMID: 3919095
  32. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).
    J Immunol. 1985 May;134(5):3179-84 PMID: 3920315
  33. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
    J Immunol. 1985 Sep;135(3):1714-8 PMID: 3926880
  34. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
    J Immunol. 1985 Sep;135(3):1719-23 PMID: 3926881
  35. Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells.
    Int J Cancer. 1985 Sep 15;36(3):337-43 PMID: 3875569
  36. The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1.
    J Immunol. 1985 Oct;135(4):2249-55 PMID: 3928742
  37. Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.
    J Natl Cancer Inst. 1985 Oct;75(4):595-603 PMID: 3876465
  38. T cell activation: differences in the signals required for IL 2 production by nonactivated and activated T cells.
    J Immunol. 1985 Dec;135(6):3669-73 PMID: 3934263
  39. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
    J Immunol. 1986 Mar 1;136(5):1888-92 PMID: 2419418
  40. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
    J Immunol. 1986 Mar 1;136(5):1893-8 PMID: 2419419
  41. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity.
    J Exp Med. 1986 Mar 1;163(3):511-9 PMID: 3485170
  42. T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to T cell proliferation.
    J Immunol. 1986 Jun 1;136(11):4106-12 PMID: 3084655
  43. Immunocytochemical detection of interleukin 1 within stimulated human monocytes.
    J Exp Med. 1986 May 1;163(5):1267-80 PMID: 3517219
  44. Presence of activated T-cells with a T8+ M1+ Leu 7+ surface phenotype in invaded lymph nodes from patients with solid tumors.
    J Natl Cancer Inst. 1986 Sep;77(3):637-41 PMID: 3091897
  45. Suppression of tumor rejection by autologous anti-idiotypic immunity.
    Proc Natl Acad Sci U S A. 1980 Apr;77(4):2209-13 PMID: 6966405
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1987-08-01
Pages
303-18
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189587
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]